Rate-responsive ventricular pacing: clinical experience with the RS4-SRT pacing system.
Eighteen patients (11 men and 7 women) with symptomatic second or third degree atrioventricular block underwent implantation of the rate-responsive RS4-SRT pacing system. Exercise tolerance in RS4 mode was compared to that in VVI mode by randomized double-blind treadmill stress testing. Following hospital discharge, RS4 function was assessed by repeat exercise testing and 24-hour Holter monitoring. Difficulty in obtaining satisfactory P-wave amplitudes at implantation (mean 3.1 +/- 1.5 mV) resulted in prolonged implantation times (mean 79.4 +/- 26.4 minutes). Following implantation, 10 patients (58%) showed a significant ventricular rate response to exercise, seven did not, and one remained in sinus rhythm. For responders, peak ventricular paced rate and double product were significantly greater in RS4 than in VVI mode, being 101.8 +/- 5.8 vs. 74.3 +/- 0.4 beats per minute and 20.1 +/- 2.9 vs. 15.5 +/- 3.7 beats per minute X mmHg X 10(-3), respectively (p less than 0.001). However, treadmill times (10.5 +/- 2.6 vs. 9.7 +/- 3.3 minutes) and work done (5.51 +/- 2.01 vs. 4.97 +/- 2.33 joules X 10(-5] were not significantly different (p = 0.22). Following hospital discharge, repeat exercise testing and 24-hour Holter monitoring demonstrated RS4 function in 11 of 16 and 15 of 18 patients, respectively. We conclude that, due to unreliable atrial sensing, the RS4-SRT pacing system does not provide the reliable rate-responsiveness required to improve exercise tolerance.
Ramsdale
D R
DR
Charles
R G
RG
D000368:Aged; D004562:Electrocardiography; D005080:Exercise Test; D005260:Female; D006327:Heart Block / Q000628:therapy*; D006339:Heart Rate; D006352:Heart Ventricles; D006801:Humans; D008297:Male; D008875:Middle Aged; D010138:Pacemaker, Artificial